drugset
drugset / Trial / NCT01710384

Effect of Antenatal Corticosteroids in Late Preterm

NCT01710384 ↗

Phase 2 Unknown 200 enrolled Meir Medical Center
RandomizedSingle-groupOpen-labelTreatment

Summary

To test the effect on premature infants of a one-time course of betamethasone administered in weeks 34-36 of gestation.

Timeline

Start
2012-11
Primary completion
2014-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 12 mg —

Indications

No indication recorded.